Rafferty Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-13,032
Closed -$127K – 1191
2024
Q2
$127K Sell
13,032
-39,291
-75% -$479K ﹤0.01% 1155
2024
Q1
$790K Buy
52,323
+391
+0.8% +$7.1K ﹤0.01% 872
2023
Q4
$1.12M Buy
51,932
+8,410
+19% +$155K ﹤0.01% 812
2023
Q3
$809K Buy
43,522
+8,479
+24% +$198K ﹤0.01% 837
2023
Q2
$887K Sell
35,043
-2,512
-7% -$63.2K 0.01% 850
2023
Q1
$973K Buy
37,555
+3,177
+9% +$85K 0.01% 809
2022
Q4
$813K Buy
34,378
+9,812
+40% +$265K 0.01% 805
2022
Q3
$623K Buy
24,566
+3,517
+17% +$123K 0.01% 806
2022
Q2
$699K Sell
21,049
-3,446
-14% -$146K 0.01% 742
2022
Q1
$1.77M Buy
24,495
+4,644
+23% +$335K 0.01% 643
2021
Q4
$1.82M Buy
19,851
+12,126
+157% +$1.45M 0.01% 699
2021
Q3
$980K Buy
7,725
+604
+8% +$87.9K 0.01% 833
2021
Q2
$1.18M Buy
7,121
+332
+5% +$53.8K 0.01% 826
2021
Q1
$1.23M Buy
6,789
+2,502
+58% +$580K 0.01% 722
2020
Q4
$857K Buy
4,287
+901
+27% +$183K 0.01% 547
2020
Q3
$742K Buy
3,386
+1,782
+111% +$377K 0.01% 622
2020
Q2
$306K Buy
+1,604
New +$281K ﹤0.01% 821

Other funds holding TDOC

Rafferty Asset Management's TDOC Position: Q3 2024 in Review

Rafferty Asset Management sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 13,032 shares — an estimated $127K sold.

Rafferty Asset Management first reported a position in TDOC in Q2 2020 and held it in 17 quarters. The position peaked at $1.82M in Q4 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Rafferty Asset Management reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 13,032 Teladoc Health shares in Q3 2024, an estimated $127K.
  • Rafferty Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 17 quarters.
  • Rafferty Asset Management's Teladoc Health position peaked at $1.82M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Rafferty Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.